London
· Delayed Price · Currency is GBP · Price in EUR Redcare Pharmacy NV Statistics
Total Valuation
Redcare Pharmacy NV has a market cap or net worth of GBP 2.00 billion. The enterprise value is 2.06 billion.
| Market Cap | 2.00B |
| Enterprise Value | 2.06B |
Important Dates
The next estimated earnings date is Tuesday, March 11, 2025.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 13.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 26.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 110.69, with an EV/FCF ratio of 110.14.
| EV / Earnings | -100.57 |
| EV / Sales | 1.09 |
| EV / EBITDA | 110.69 |
| EV / EBIT | n/a |
| EV / FCF | 110.14 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.46.
| Current Ratio | 2.12 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 11.18 |
| Debt / FCF | 10.87 |
| Interest Coverage | -1.65 |
Financial Efficiency
Return on equity (ROE) is -4.56% and return on invested capital (ROIC) is -1.10%.
| Return on Equity (ROE) | -4.56% |
| Return on Assets (ROA) | -0.86% |
| Return on Capital (ROIC) | -1.10% |
| Revenue Per Employee | 975,253 |
| Profits Per Employee | -10,758 |
| Employee Count | 2,074 |
| Asset Turnover | 2.11 |
| Inventory Turnover | 12.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.71% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.71% |
| 50-Day Moving Average | 141.63 |
| 200-Day Moving Average | 132.05 |
| Relative Strength Index (RSI) | 29.57 |
| Average Volume (20 Days) | 7,731 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Redcare Pharmacy NV had revenue of GBP 1.85 billion and -20.44 million in losses.
| Revenue | 1.85B |
| Gross Profit | 429.93M |
| Operating Income | -12.09M |
| Pretax Income | -24.46M |
| Net Income | -20.44M |
| EBITDA | 12.92M |
| EBIT | -12.09M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 174.66 million in cash and 202.81 million in debt, giving a net cash position of -28.15 million.
| Cash & Cash Equivalents | 174.66M |
| Total Debt | 202.81M |
| Net Cash | -28.15M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 444.82M |
| Book Value Per Share | n/a |
| Working Capital | 226.47M |
Cash Flow
In the last 12 months, operating cash flow was 25.80 million and capital expenditures -7.13 million, giving a free cash flow of 18.66 million.
| Operating Cash Flow | 25.80M |
| Capital Expenditures | -7.13M |
| Free Cash Flow | 18.66M |
| FCF Per Share | n/a |
Margins
Gross margin is 23.20%, with operating and profit margins of -0.65% and -1.10%.
| Gross Margin | 23.20% |
| Operating Margin | -0.65% |
| Pretax Margin | -1.32% |
| Profit Margin | -1.10% |
| EBITDA Margin | 0.70% |
| EBIT Margin | -0.65% |
| FCF Margin | 1.01% |
Dividends & Yields
Redcare Pharmacy NV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.02% |
| FCF Yield | 0.93% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |